RadNet, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- RadNet, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $509.00K, a 17.28% increase year-over-year.
- RadNet, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $103.00K, a 14.88% decline year-over-year.
- RadNet, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $3.19M, a 963.67% increase year-over-year.
- RadNet, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $1.70M.
- RadNet, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $5.45M, a 717.09% increase from fiscal 2024.
- RadNet, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $667.00K, a 369.72% increase from fiscal 2023.
- RadNet, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $142.00K, a 51.86% decline from fiscal 2022.
- RadNet, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $295.00K, a 39.55% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $509.00K 10-Q · filed 2026-08-10 | $5.51M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $103.00K 10-Q · filed 2026-05-11 | $5.43M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $3.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $5.45M 10-K · filed 2026-03-02 |
| 2025-09-30 | $1.70M 10-Q · filed 2025-11-10 | $2.56M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $434.00K 10-Q · filed 2026-08-10 | $855.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $121.00K 10-Q · filed 2026-05-11 | $780.00K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $667.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $437.00K derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $359.00K 10-Q · filed 2025-08-11 | $458.00K derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $8.00K 10-Q · filed 2025-05-12 | $99.00K derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $142.00K 10-K · filed 2026-03-02 |
| 2023-09-30 | $21.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | |
| 2023-03-31 | $51.00K 10-Q · filed 2024-05-10 | |
| 2022-12-31 | $295.00K 10-K · filed 2025-03-03 | |
| 2021-12-31 | $488.00K 10-K · filed 2024-02-29 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | |
| 2015-06-30 | $270.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | |
| 2015-03-31 | $324.00K 10-Q · filed 2015-05-11 | |
| 2014-09-30 | $760.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | |
| 2014-06-30 | $757.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | |
| 2014-03-31 | $29.00K 10-Q · filed 2014-05-12 | |
| 2013-03-31 | $469.00K 10-Q · filed 2013-05-10 | |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-13 | $242.00K 10-K · filed 2012-03-13 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | |
| 2010-12-31 | $271.00K 10-K · filed 2012-03-13 | |
| 2009-12-31 | $16.00K 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |